Clinical Trials Browser

Has results × Lung Neoplasms × Classical hematology × Clear all

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

NCT01444456 2017-03-20

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicThoracic

Anemia, Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT01813721 2017-03-15

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Completed

1,007 enrolled 9 charts

BreastClassical hematologyThoracic

Breast Neoplasms, Lung Neoplasms, Chemotherapy-Induced Febrile Neutropenia

NCT01459653 2016-01-11

Monitor-GCSF

Completed

1,496 enrolled 120 charts

BreastClassical hematologyGenitourinaryGynecologicLymphoidPlasma cellThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Lymphoma, B-Cell, Febrile Neutropenia

NCT00413283 2013-10-24

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

63 enrolled 15 charts

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Thrombocytopenia

Clinical Trials

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Monitor-GCSF

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)